Medical Lead, France

JobsCloseBy Editorial Insights

Blueprint Medicines seeks a Medical Lead in France, a Director-level, full-time, onsite role in Paris reporting to the VP of International Medical Affairs with a dotted line to the VP and GM Region South. You will own the medical strategy for France, lead the in-country MSLs, co-own the TRIAD with commercial and market access, and drive local evidence generation to support avapritinib launches for systemic mastocytosis and future pipeline work. Translate global priorities into local execution, engage healthcare professionals, patient groups, authorities, and ensure medical ethics and regulatory compliance. Ideal candidates hold an advanced clinical science degree, 5-10 years in medical affairs, launch leadership, and fluency in French and English. Apply by highlighting launch outcomes, cross-functional leadership, KOL network in France, payer/HTA experience, and alignment with our core values.

Location(s): France

Level of position: Director

Position type: Office-based

Reporting Line: This position reports to the Vice President of International Medical Affairs

How will your role help us transform hope into reality?

The Medical Lead (Associate Director) is a country-level medical leader responsible for driving the medical strategy and execution of Blueprint Medicines’ portfolio in France. This role will provide leadership to the in-country medical team, shaping strategic priorities, ensuring cross-functional alignment, and supporting the successful launch and lifecycle management of our products.

Our main medical focus is the launch of avapritinib in indications for systemic mastocytosis (SM), as well as advancing our pipeline in the same space and in immunology.

As the senior medical partner in France, you will act as a scientific and strategic expert, ensuring the translation of global and regional medical strategies into impactful local execution. You will foster external collaborations with key stakeholders, provide leadership in evidence generation, and deliver medical insights to support access and patient outcomes.

Reporting to the VP Medical Affairs International and dotted line to the VP & General Manager Region South the Medical Lead's mission will be to improve and extend life for as many people with cancer and hematological and allergic disorders as possible

What will you do?

• Is a key member of the French Leadership Team as well as of the International Medical Affairs Leadership Team
• Co-owns the TRIAD strategy for France together with commercial and market access leads for France ensuring strong cross-functional alignment and collaboration
• Will set the medical strategy for France and the field-based Medical Science (MSL) team, develops and owns the Medical Plan and ensures execution, in alignment with regional and global priorities
• Provides scientific input into the development of local marketing material and is accountable for medical approval of all marketing and sales strategies and programs to ensure the highest degree of medical and ethical standards, in compliance with corporate standards and government/industry regulations.
• Supports local, regional and global market access colleagues on strong price and reimbursement strategies and dossiers that will be tested extensively with medical experts and national leaders who may also have to represent it to reimbursement authorities.
• Provide leadership, coaching, and guidance to in-country MSLs and medical colleagues.
• In Alignment with the French Senior MSL ensures MSL performance to goals.
• Will be challenged to foster top class dynamic and nimble field teams that allow for local decision making, autonomy and flexibility while maintaining the MSLs as the vital link for effective Medical Affairs activities in the field.
• Act as the primary scientific and medical leader for the French affiliate, representing the company in interactions with healthcare professionals, patient associations, and other external stakeholders.
• Closely liaises with Clinical development-, Clinical Operations- and Global Medical Affairs teams to review and supervise local clinical programs. Support investigator/selection management. Ensures a strategic approach to such programs, and the development of clinical data to support the appropriate use of the Company's products.
• Leads local evidence generation activities, including company-sponsored studies, investigator-initiated trials (IITs), and real-world evidence initiatives.
• Supports and leads advisory boards, expert meetings, and congress activities at a national level and delivers high-quality medical education and scientific exchange with external experts across relevant therapeutic areas.
• Ensures compliance with local laws and regulations, industry codes, and company policies in all activities.
• Support resource and budget planning and management to ensure the medical needs and opportunities are met in alignment with commercial.
• Remains informed of current developments within pertinent medical and scientific communities through familiarity with current literature, attendance at meetings, conventions, professional associations, etc.
• Continuously expands medical and scientific knowledge and maintains an awareness of relevant industry and market trends (i.e., competitive, technological, social and economic).

What minimum qualifications do we require?

• Advanced Clinical Science degree required (Medical Doctor, PharmD, PhD or MSc)
• 5-10 years experience in medical affairs in the biopharmaceutical industry.
• Demonstrable experience in the development and management of launches
• Proven Leadership and people management experience
• Effective communicator with Fluency in French and English

What additional qualifications will make you a stronger candidate?

• Experience in allergy, immunology, hematology, and/or rare diseases strongly preferred.
• Demonstrated success in leading affiliate-level medical strategy and cross-functional projects.
• Strong external stakeholder engagement and established KOL network in France.
• Experience in health authority interactions, HTA/reimbursement processes, or patient advocacy collaborations.
• Entrepreneurial mindset, adaptability, and ability to operate in a fast-paced, high-growth environment.
• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

Why Blueprint? 

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

Blueprint Medicines, a Sanofi company, is a global biopharmaceutical company that seeks to improve and extend patients' lives by solving important medical problems, with a focus on allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a track record of success,leveraging our established research, development, and commercial capability and infrastructure, we aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases and solid tumors. For more information, visit www.BlueprintMedicines.com and follow us on X (formerly Twitter; @BlueprintMeds) and LinkedIn.

*Blueflex is our operating model which optimizes culture, productivity, & flexibility by maximizing the critical strengths of in-person work with the benefits of added flexibility.  Blueflex allows for mix of in-office and remote work, enables flexibility to meet individual and business needs and makes effective use of our facilities and resources.  It is a culture enhancer.